IP Library Granted Patent US 7,750,163
Granted Patent B2
US 7,750,163 · App. 10/576,956 · Granted Jul 6, 2010

Cyanine dye labelling reagents

Assignees: GE Healthcare U.K. Limited; Carnegie Mellon University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,750,163
App. No.
10/576,956
Granted
Jul 6, 2010
Kind
B2
Abstract

Disclosed are cyanine dyes that are useful for labeling and detecting biological and other materials. The dyes are of formula (I) in which groups R 3 and R 4 are attached to the Z 1 ring structure and groups R 5 and R 6 are attached to the Z 2 ring structure, and n=1, 2 or 3; Z 1 and Z 2 independently represent the carbon atoms necessary to complete a one ring, or two-fused ring aromatic system; at least one of groups R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 is the group -E-F where E is a single bond or a spacer group and F is a target bonding group; one or more of groups R 11 , R 12 , R 13 and R 14 are independently selected from the group —(CH 2 ) k —W, where W is sulphonic acid or phosphonic acid and k is an integer from 1 to 10. The dyes may be used in fluorescence labeling applications, where the presence of one and preferably multiple water solubilising groups attached to the 3-position of the indolinium ring reduces dye-dye interactions, and hence dye-dye quenching, particularly where multiple dye molecules are attached to components such as nucleic acids, oligonucleotides, proteins and antibodies.

Claims (38)

1. A compound of formula (I):

wherein:

Z 1 and Z 2 independently represent the carbon atoms necessary to complete a one ring, or two-fused ring aromatic system;

R 1 and R 2 are independently chosen from the group -E-F, C 1 -C 6 alkyl, benzyl either unsubstituted or substituted with sulphonic acid, and the group —(CH 2 ) k —W,

where W is sulphonic acid or phosphonic acid and k is an integer from 1 to 10;

R 3 and R 4 are attached to the Z 1 ring structure and groups R 5 and R 6 are attached to the Z 2 ring structure, and n=1, 2 or 3;

R 3 , R 4 , R 5 and R 6 are independently selected from the group -E-F, hydrogen and sulphonic acid;

each R 7 is independently the group -E-F, hydrogen or two of R 7 together with the group,

form a hydrocarbon ring system having 5 or 6 atoms;

each R 11 , R 12 , R 13 and R 14 is independently a group —(CH 2 ) k —W as defined above, or C 1 -C 6 alkyl;

E is a single bond or a spacer group having a chain from 1-20 linked atoms selected from the group consisting of carbon, nitrogen and oxygen atoms and F is a target bonding group;

wherein F is either:

(i) a reactive group selected from carboxyl, succinimidyl ester, sulpho-succinimidyl ester, isothiocyanate, maleimide, haloacetamide, acid halide, hydrazide, vinylsulphone, dichlorotriazine and phosphoramidite; or

(ii) a functional group selected from hydroxy, amino, sulphydryl, carbonyl (including aldehyde and ketone) and thiophosphate; or

(iii) an affinity tag;

with the provisos that:

(a) one of groups R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 is the group -E-F;

(b) one or more of R 11 , R 12 , R 13 and R 14 is the group —(CH 2 ) k —W;

(c) the compound of Formula I has from 3 to 5 sulfonic acid groups.

2. A compound according to claim 1 wherein at least two of R 11 , R 12 , R 13 and R 14 are independently —(CH 2 ) k —W.

3. A compound according to claim 1 wherein one of groups R 11 and R 12 and one of groups R 13 and R 14 is the group —(CH 2 ) k —W.

4. A compound according to claim 1 wherein W is sulphonic acid.

5. A compound according to claim 1 wherein —(CH 2 ) k —W is selected from —(CH 2 ) 3 —SO 3 H and —(CH 2 ) 4 —SO 3 H.

6. A compound according to claim 1 wherein Z 1 and Z 2 are selected from phenyl and naphthyl moieties.

7. A compound according to claim 1 wherein said target bonding group F comprises an affinity tag.

8. A compound according to claim 1 wherein said spacer group E is selected from:

—(CHR′) p -Q-(CHR′) r —

where Q is selected from: —CHR′—, —NR′, —O—, —CR′═CR′—, —C(O)—NR′— and —C(O)—O—;

R′ is hydrogen or C 1 -C 4 alkyl, p is 0-5 and r is 1-5.

9. A compound according to claim 8 wherein Q is selected from: —CHR′—, —C(O)—NH— and

where R′ is hereinbefore defined.

10. A compound according to claim 1 wherein said group -E-F comprises a carboxypentyl group.

11. A compound according to claim 1 selected from:

i) 2-{(1E,3E,5E)-5-[1-(5-carboxypentyl)-3-methyl-5-sulpho-3-(4-sulphobutyl)-1,3-dihydro-2H-indol-2-ylidene]penta-1,3-dienyl}-1-ethyl-3-methyl-3-(4-sulphobutyl)-3H-indolium-5-sulphonate;

ii) 2-{(1E,3E,5E)-5-[1-(5-carboxypentyl)-3-methyl-5-sulpho-3-(4-sulphobutyl)-1,3-dihydro-2H-indol-2-ylidene]penta-1,3-dienyl}-3-methyl-1,3-bis(4-sulphobutyl)-3H-indolium-5-sulphonate;

iii) 2-{(1E,3E,5E,7E)-7-[1-(5-carboxypentyl)-3-methyl-5-sulpho-3-(4-sulphobutyl)-1,3-dihydro-2H-indol-2-ylidene]hepta-1,3,5-trienyl}-1-ethyl-3-methyl-3-(4-sulphobutyl)-3H-indolium-5-sulphonate;

iv) 2-{(1E,3E,5E,7E)-7-[5-(carboxymethyl)-3-methyl-1,3-bis(4-sulphobutyl)-1,3-dihydro-2H-indol-2-ylidene]hepta-1,3,5-trienyl}-1-ethyl-3-methyl-3-(4-sulphobutyl)-3H-indolium-5-sulphonate; and

v) 1-benzyl-2-{(1E,3E,5E)-5-[1-(5-carboxypentyl)-3-methyl-5-sulpho-3-(4-sulphobutyl)-1,3-dihydro-2H-indol-2-ylidene]penta-1,3-dienyl}-3-methyl-3-(4-sulphobutyl)-3H-indolium-5-sulphonate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2006
From: WEST, RICHARD M.; BOSWORTH, NIGEL; MUJUMDAR, RATNAKAR B.
To: GE HEALTHCARE UK LIMITED; CARNEGIE MELLON UNIVERSITY
Reel/Frame 018553/0263 →
Continuity (2)
Provisional Application 6051642800 · Oct 31, 2003
Related Publication 20070203343A1 · Aug 30, 2007